Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?

Novo Nordisk (NVO) closed the last trading session at $67.55, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 102.16 indicates a 51.2% upside potential.The average comprises nine short-term price targets ranging from a low of $61 to a high of$ 160, with a standard deviation of $36.83. While the lowest estimate indicates a decline of 9.7% from the current price level, ...